493 related articles for article (PubMed ID: 30599875)
1. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
2. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
Zeng P; Ma L; Liu J; Song Z; Liu J; Yuan H
Eur J Radiol; 2022 May; 150():110261. PubMed ID: 35316674
[TBL] [Abstract][Full Text] [Related]
6. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
[No Abstract] [Full Text] [Related]
7. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
[TBL] [Abstract][Full Text] [Related]
9. Nonhypovascular pancreatic ductal adenocarcinomas: CEUS imaging findings and differentiation from other types of solid pancreatic lesions.
Wang L; Nie F; Dong T; Yin C; Li M; Li Y
Clin Hemorheol Microcirc; 2022; 81(2):163-176. PubMed ID: 35253738
[TBL] [Abstract][Full Text] [Related]
10. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
[TBL] [Abstract][Full Text] [Related]
11. Differential Diagnosis of Nonhypervascular Pancreatic Neuroendocrine Neoplasms From Pancreatic Ductal Adenocarcinomas, Based on Computed Tomography Radiological Features and Texture Analysis.
Yu H; Huang Z; Li M; Wei Y; Zhang L; Yang C; Zhang Y; Song B
Acad Radiol; 2020 Mar; 27(3):332-341. PubMed ID: 31495760
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
Belousova E; Karmazanovsky G; Kriger A; Kalinin D; Mannelli L; Glotov A; Karelskaya N; Paklina O; Kaldarov A
Clin Radiol; 2017 Feb; 72(2):150-158. PubMed ID: 27890421
[TBL] [Abstract][Full Text] [Related]
13. Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology.
Zamboni GA; Ambrosetti MC; Zivelonghi C; Lombardo F; Butturini G; Cingarlini S; Capelli P; Pozzi Mucelli R
HPB (Oxford); 2017 Nov; 19(11):986-991. PubMed ID: 28784262
[TBL] [Abstract][Full Text] [Related]
14. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.
Kim JH; Eun HW; Kim YJ; Lee JM; Han JK; Choi BI
Eur Radiol; 2016 May; 26(5):1338-47. PubMed ID: 26253257
[TBL] [Abstract][Full Text] [Related]
16. Can MDCT or EUS features predict the histopathological grading scheme of pancreatic neuroendocrine neoplasms?
Zhu H; Ying L; Tang W; Yang X; Sun B
Radiol Med; 2017 May; 122(5):319-326. PubMed ID: 28176217
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
[TBL] [Abstract][Full Text] [Related]
18. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography.
Kitano M; Kudo M; Yamao K; Takagi T; Sakamoto H; Komaki T; Kamata K; Imai H; Chiba Y; Okada M; Murakami T; Takeyama Y
Am J Gastroenterol; 2012 Feb; 107(2):303-10. PubMed ID: 22008892
[TBL] [Abstract][Full Text] [Related]
19. Differentiating pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas by the "Duct-Road Sign": A preliminary magnetic resonance imaging study.
Xiao B; Jiang ZQ; Hu JX; Zhang XM; Xu HB
Medicine (Baltimore); 2019 Aug; 98(35):e16960. PubMed ID: 31464937
[TBL] [Abstract][Full Text] [Related]
20. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]